FP6Индивидуална стипендия2007–2009

PGC1SS IN BRAIN · Role of PGC 1ß co-activator in the brain: energy homeostasis, obesity, ageing and neuronal death

6РП — Действия „Мария Кюри“

Период
2007-09-11 → 2009-09-10
Финансиране от ЕС
160 180 €
Участници
1
Схема
IIF

Линиите свързват координатора с партньорите.

Накратко на български

Ролята на коактиватора PGC-1ß в хипоталамуса се анализира чрез проследяване на мазните вещества и стреса в клетките при мишки. Това помага да се разбере как се развиват затлъстяването, диабетът и увреждането на невроните.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Final Activity Report Summary - PGC1? IN BRAIN (Role of PGC 1? coactivator in the brain: energy homeostasis, obesity, ageing and neuronal death)

The development of obesity requires the existence of positive energy balance and is strongly associated with insulin resistance and diabetes. One of the hypotheses to explain the relation between obesity and diabetes is the concept of lipid induced toxicity or lipotoxicity. Of specific relevance for this project is the role of PGC-1 beta in the lipid homeostasis and its relevance in the lipotoxic damage. One of the mechanisms how lipids can be toxic is through the induction of endoplasmic reticulum (ER) stress response. The term 'ER stress' refers to the perturbation of the protein folding functionality of the ER resulting in apoptotic cell death. ER stress has also been observed in the adipose tissue of obese models in rodents and human biopsies. Thus, we extended the concept of PGC1 beta in the energy homeostasis failure induced by lipotoxicity to the hypothalamus, a region of the CNS specialized in the control of energy balance, and investigated whether hypothalamic ER stress may be the cause, consequence or contribute to maintain a vicious cycle promoting energy deregulation and metabolic derangement. Also, we investigated whether the specific nutrient composition may influence the development of ER stress in the hypothalamus of PGC 1 beta KO and its association with and the severity of metabolic disturbance. Given the fact that PGC-1ß is involved in the lipid handling under positive energy balance in liver, we wondered whether under physiological conditions the absence of this coactivator may be associated with failure in the brain lipid homeostasis. Hypothalamic gene expression of PGC-1ß KO mice showed a decrease in the gene expression related with lipid metabolism like SREBP1c, LXRbeta and RXRbeta. We wondered whether the failure in lipids handling of PGC-1ß mice may result in physiologically ER stress response. We found a significant increase in the basal XBPs and CHOP gene expression, and upregulation in the basal protein content of GRP78 and CHOP, three genes related with ER stress response. We found also that ER stress pathway activation is disturbed in PGC-1ß KO mice exposed to six months high fat diet. As in vivo, neuronal culture from PGC-1ß KO mice are insensitive to respond to pharmacologic ER stress stimulation by tunicamycin or thapsigargin, compared to WT mice. These experiments provided new information about the role of PGC-1ß in the ER stress response associated to lipid homeostasis and its role in the energy homeostasis.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

Food intake and energy expenditure are the main components of energy balance and both are regulated by the central nervous system (CNS). Failure of these homeostatic mechanisms results in deregulation of lipid and glucose metabolism leading to insulin resistance and obesity.Defects in energy homeostasis may impact neuronal survival and accelerate the neurodegenerative process associated with ageing. The CNS receives peripheral nutritional signals that acting on specific hypothalamic nuclei and controls the energy balance. PGC1a is a coactivator of several transcription factors, involved in thermogenesis, mitochondrial biogenesis and energy expenditure; and its genetic ablation generates lesions in the striatal region of the brain.My project will focus on P GC1ß, a new coactivator homologous to PGC1a, which is highly expressed in heart, skeletal muscle and relevant for this proposal also in brain. Our aim is to understand the role of PGC1ß in the brain lipid and glucose homeostasis and their pathological states such as insulin resistance, obesity, neuronal death and ageing.I will investigate these using two complementary strategies:- I will characterize the specific pattern of PGC1ß gene expression in the mouse brain using a PGC1ß promoter driven GFP transgenic mouse model and- I will characterize the effects of PGC1ß in brain using the PGC1ßKO and if necessary neuron/nuclei specific PGC1ßKO mouse models using a Cre/lox approach.To investigate these aims we will use genetically modified mouse models combined with- transcriptomic profiling,- cerebral imaging analysis, complemented with- intracerebral stereotaxic injections of viruses over-expressing PGC1a and ß and d) electrophysiologic techniques.The relevance of the outcome of the study will be the extensive characterization of the role of PGC1ß on insulin sensitivity and PGC1ß mediated ageing effects on neuronal survival.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз